Baird Medical Investment Holdings Limited (BDMD)
| Market Cap | 95.72M |
| Revenue (ttm) | 33.05M |
| Net Income (ttm) | 12.55M |
| Shares Out | 35.45M |
| EPS (ttm) | 0.43 |
| PE Ratio | 6.72 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,981 |
| Open | 2.710 |
| Previous Close | 2.866 |
| Day's Range | 2.512 - 2.850 |
| 52-Week Range | 2.490 - 13.520 |
| Beta | 0.14 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BDMD
Baird Medical Investment Holdings Limited, along with its subsidiaries manufactures microwave ablation and other medical devices for minimally invasive tumor treatment. The company was founded in 2012 and is headquartered in Guangzhou, China. [Read more]
Financial Performance
In 2023, BDMD's revenue was $31.46 million, a decrease of -10.35% compared to the previous year's $35.09 million. Earnings were $10.55 million, a decrease of -16.09%.
Financial numbers in USD Financial StatementsNews
Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event...
Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
NEW YORK , Nov. 4, 2024 /PRNewswire/ -- Baird Medical (Nasdaq: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly participated in the 2024 American Thyroid Association ...
Baird Medical Advances Global Academic Collaboration in Thyroid Health
NEW YORK , Oct. 28, 2024 /PRNewswire/ -- From October 24-27, Baird Medical proudly invited and gathered leading experts from the U.S. and China to advance the field of thyroid care through a series of...
Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
NEW YORK , Oct. 24, 2024 /PRNewswire/ -- Baird Medical, (NASDAQ: BDMD) a global leader in minimally invasive microwave ablation (MWA) technology, successfully participated in the prestigious 2024 Amer...
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
NEW YORK , Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medica...
Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024
Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth Net income reached US$4.4 million, representing 85.8% year-over-year growth GUANGZHOU, China , Oct. 11, 2024 /PRNe...
Baird Medical Lists in the U.S. on the Nasdaq Exchange
Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C. , Oct. 9, 2024 /PRNewswire/ -- Baird Me...
Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference
GUANGZHOU, China , Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer ...
Baird Medical and ExcelFin Acquisition Corp Complete Business Combination
NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in Ch...
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement
FORT MILL, S.C. , Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provid...
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders
Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty a...
ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled for October 18, 2023 (the "Speci...
Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.
Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share in China [1] Extensive distribution network with over 430 hospitals pene...
ExcelFin Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 13, 2021
SAN FRANCISCO, Dec. 15, 2021 /PRNewswire/ -- ExcelFin Acquisition Corp. (Nasdaq: XFIN) (the "Company") announced today that commencing December 13, 2021, holders of the units sold in the Company's ini...